Winter W.d., Post T., Jongh J.d., Urquhardt R., Moules I., Eckland D. and Danhof M.A., Mechanistic Disease Progression Model for Type 2 Diabetes Mellitus and Pioglitazone Treatment Effects. PAGE.(2004). [Link to publication]
Winter W.d., Post T.M., Jongh J.d., Moules I., Urquhart R., Eckland D. and Danhof M., Disease Progression Analysis for Type 2 Diabetes Mellitus: Bridging Therapeutic Intervention and Disease Outcome. Figon.(2004).
Winter W.d., Jongh J.d., Eckland D. and Danhof M., Towards a Mechanistic Disease Progression Model for Type 2 Diabetes Mellitus. ASCPT.(2004).
Winter W.d., Jongh J.d., Moules I., Urquhart R., Eckland D. and Danhof M., Mechanistic Disease Progression Analysis Indicates that Pioglitazone Prevents the Progression of T2DM. ADA.(2004).
Winter W.d., Jongh J.d., Urquhart R., Moules I., Eckland D. and Danhof M., Mechanistic Disease Progression Analysis Indicates that Pioglitazone Impedes the Progression of Type 2 Diabetes Mellitus (T2DM) in Combination Therapy with Sulphonylurea and Metformin. EASD.(2004).
Winter W.d., Jongh J.d., and Danhof M., Integrating multiple biomarker into a single mechanistic model cascade of disease processes. cost b15.(2004).
- « Previous
- 1
- 2
- 3